Karen Martin

1PUBLICATIONS
5CO-AUTHORS
Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Oct 26, 2021
An Open Label, Adaptive, Phase 1 Trial of High-Dose Oral Nitazoxanide in Healthy Volunteers: An Antiviral Candidate for SARS-CoV-2.

Lauren E Walker, Richard FitzGerald, Geoffrey Saunders

Pageof 1